Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice

Xiaopeng Li1, Liang Wang1, Xiaoyu Cheng1

  • 1Department of Infectious Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

Scientific Reports
|December 15, 2025
PubMed

Insights

Circadian disruption worsens non-alcoholic fatty liver disease (NAFLD) by promoting Kupffer cell necroptosis via the RIPK1/RIPK3/MLKL pathway. This highlights a new mechanism and potential therapeutic target for NAFLD.

Area of Science:

  • Hepatology and Metabolic Diseases
  • Chronobiology and Molecular Pathways

Background:

  • Circadian rhythm disruption is a known risk factor for non-alcoholic fatty liver disease (NAFLD).
  • The molecular mechanisms linking circadian disruption to NAFLD pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the impact of circadian disruption on NAFLD development in a mouse model.
  • To elucidate the molecular pathways, specifically necroptosis in Kupffer cells, involved in this process.

Main Methods:

  • Established a 12-week high-fat diet-induced NAFLD mouse model with concurrent circadian disruption.
  • Assessed liver function, lipid accumulation, inflammation, fibrosis, apoptosis, and necroptosis markers (RIPK1/3, MLKL).
  • Utilized biochemical assays, ELISA, HE/Masson/Sirius Red staining, TUNEL assay, Western blotting, and immunofluorescence.

Main Results:

  • Circadian disruption significantly increased lipid accumulation and impaired liver function in NAFLD mice.
  • NAFLD with circadian disruption showed enhanced collagen deposition and elevated fibrosis and necroptosis markers.
  • Circadian disruption promoted Kupffer cell necroptosis by activating the RIPK1/RIPK3/MLKL pathway in NAFLD livers.

Conclusions:

  • Circadian rhythm disruption exacerbates NAFLD by promoting Kupffer cell necroptosis through the RIPK1/RIPK3/MLKL pathway.
  • This study reveals a novel mechanism linking circadian disruption to NAFLD progression.
  • Targeting this pathway offers a potential new therapeutic strategy for NAFLD prevention and treatment.